Although a CSC marker for ovarian clear cell adenocarcinoma is yet to be identified, CD44v6 and aldehyde dehydrogenase 1 (ALDH1) activities are considered in the literature as candidates for CSC markers [16, 17]. This evidence concerns the gene ALDH1A1 and ovarian clear cell adenocarcinoma.